Monoclonal antibody to tumor necrosis factor-α attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats

Critical Care Medicine

Volumn 24, Issue 9, 1996, Pages 1547-1553

  Yao, Yong Ming ^a   Bahrami, Soheyl ^a   Redl, Heinz ^a   Schlag, Guenther ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

bacterial; cardiovascular dysfunction; critical illness; endotoxin; hemodynamics; intestine, small; ischemia reperfusion; monoclonal antibody; survival rate; translocation; tumor necrosis factor

Indexed keywords

ENDOTOXIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HYPOTENSION; INTESTINE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; SURVIVAL RATE; VASCULAR RESISTANCE;

EID: 0029788438     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199609000-00020     Document Type: Article

References (44)

1. Wilson C, Gupta R, Gilmour DG, et al: Acute superior mesenteric ischaemia. Br J Surg 1987; 74:279-281
2. Levy PJ, Krausz MM, Manny J: Acute mesenteric ischemia: Improved results - A retrospective analysis of ninety-two patients. Surgery 1990; 170: 372-380
3. Caty MG, Guice KS, Oldham KT, et al: Evidence of tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion. Ann Surg 1990; 212:694-700
4. Sheng ZY, Dong YL, Wang XH: Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma 1992; 32:148-153
5. Koike K, Moore EE, Moore FA, et al: Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 1994; 22:1438-1444
6. Yao YM, Sheng ZY, Yu Y, et al: The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury. Resuscitation 1995; 29:157-168
7. Simpson R, Alon R, Kobzik L, et al: Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 1993; 218:444-454
8. 2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am J Surg 1987; 57:562-566
9. Granger D, Hollwarth M, Parks D: Ischemia-reperfusion injury: Role of oxygen-derived free radicals. Acta Physiol Scand 1986; 548(Suppl):47-63
10. Mozes T, Braquet P, Filep J: Platelet-activating factor: An endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 1989; 257:R872-R877
11. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21: S423-S435
12. Colletti LM, Remick DG, Burtch GD, et al: Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85:1936-1943
13. Sakr M, Zetti G, McClain C, et al: The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992; 53: 987-991
14. Squadrito F, Ioculano M, Altavilla D, et al: Platelet activating factor interaction with tumor necrosis factor in myocardial ischemia-reperfusion injury. J Lipid Mediat 1993; 8:53-65
15. Bodmer M, Fournel MA, Hinshaw LB: Preclinical review of anti-tumor necrosis factor monoclonal antibodies. Crit Care Med 1993; 21:8441-8446
16. Bahrami S, Schlag G, Yao YM, et al: Involvement of endotoxin, tumour necrosis factor, and nitric oxide in haemorrhagic shock-related alterations. In: Shock, Sepsis, and Organ Failure - Nitric Oxide: Fourth Wiggers Bernard Conference 1994. Schlag G, Redl H (Eds). Berlin, Heidelberg, Springer-Verlag, 1995, pp 59-76
17. Squadrito F, Altavilla D, Ioculano M, et al: Passive immunization with antibodies against tumor necrosis factor (TNF-α) protects from the lethality of splanchnic artery occlusion shock. Circ Shock 1992; 37:236-244
18. Marzi I, Bauer M, Secchi A, et al: Effects of anti-tumor necrosis factor α on leukocyte adhesion in the liver after hemorrhagic shock: An intravital microscopic study in the rat. Shock 1995; 3:27-33
19. Marston A: Vascular occlusion. In: Splanchnic Ischemia and Multiple Organ Failure. Marston A, Bulkley GB, Fiddian-Green RG, et al (Eds). London, Edward Arnold, 1989, pp 51-71
20. Bahrami S, Leichtfried G, Redl H, et al: A kinetic chromogenic method to determine endotoxin on microplates. Eur Clin Lab News 1991; 10:8-9
21. Sheehan KCF, Ruddle NH, Schreiber RD: Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factor. J Immunol 1989; 142:3884-3893
22. Suitters AJ, Foulkes R, Opal SM, et al: Differential effect of isotype on efficacy of anti-tumor necrosis factor α chimeric antibodies in experimental septic shock. J Exp Med 1994; 179:849-856
23. Von Asmuth EJ, Maessen JG, Van der Linder CJ, et al: Tumor necrosis factor-alpha (TNF) and interleukin 6 in a zymosan induced shock model. Scand J Immunol 1990; 32:313-319
24. Schirmer WJ, Schirmer JM, Fry DE: Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 1989; 124:445-448
25. Schlag G, Redl H, Davies J, et al: Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 1994; 2:10-18
26. Willms CD, Dawidson IJA, Armstrong JM, et al: Pentafraction - Du Pont versus albumin for resuscitation of a lethal intestinal ischemic shock in rats. Circ Shock 1991; 33:216-221
27. Yokoyama T, Vaca L, Rossen RP, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92:2302-2312
28. Weisensee D, Bereiter-Hain J, Schoeppe W, et al: Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol 1993; 15:581-587
29. Vincent J-L, Bakker J, Marecaux G, et al: Administration of anti-TNF antibody improves left ventricular function in septic shock patients: Results of a pilot study. Chest 1992; 101:810-815
30. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implication for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-3632
31. Takahashi K, Ando K, Ano A, et al: Tumor necrosis factor-α induces vascular hyporesponsiveness in Sprague-Dawley rats. Life Sci 1992; 50:1437-1444
32. Zingarelli B, Squadrito F, Altavilla D, et al: Role of tumor necrosis factor-α in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 1994; 266: H1512-H1515
33. Zweier JL, Wang P, Kuppusamy P: Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 1995; 270: 304-307
34. Okusawa S, Gelfand JA, Ikejima T, et al: Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81:1162-1172
35. Fong Y, Tracey KJ, Moldawer LL, et al: Antibodies to cachectin/tumor necrosis factor reduce interleukin-1 β and interleukin-6 appearance during lethal bacteremia. J Exp Med 1989; 17: 1627-1633
36. Redl H, Schlag G, Schießer A, et al: Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons. Am J Physiol 1993; 264: H2119-H2123
37. Yao YM, Tian HM, Sheng ZY, et al: Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/bacterial translocation and cytokine formation in rats. J Trauma 1995; 38:924-930
38. Kawano K, Kim YI, Kai T, et al: Evidence that FK506 alleviates ischemia/ reperfusion injury to the rat liver: In vivo demonstration for suppression of TNF-α production in response to endotoxemia. Eur Surg Res 1994; 26:108-115
39. Jiang JX, Bahrami S, Leichtfried G, et al: Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 1995; 221: 100-106
40. Cabie A, Farkas JC, Fitting C, et al: High levels of portal TNF-α during abdominal aortic surgery in man. Cytokine 1993; 5:448-453
41. Rush BF, Sori AJ, Murphy TF, et al: Endotoxemia and bacteremia during hemorrhagic shock: The link between trauma and sepsis? Ann Surg 1988; 207:549-552
42. Yao YM, Bahrami S, Leichtfried G, et al: Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats: Effects of recombinant bactericidal/permeability-increasing protein. Ann Surg 1995; 221:398-105
43. Schlag G, Redl H, Davies J, et al: Bacterial translocation during traumatic shock in baboons. In: Pathophysiology of Shock, Sepsis, and Organ Failure. Schlag G, Redl H (Eds). Berlin, Heidelberg, Springer-Verlag, 1993, pp 279-291
44. Deitch EA, Berg RD: Bacterial translocation from the gut: A mechanism of infection. J Burn Care Rehabil 1987; 8: 475-482